If you enjoy this content, please share it with a colleague
RELATED CONTENT
August 5, 2015 — The Alzheimer’s Association announced the launch of a new website for the upcoming Imaging Dementia — ...
A new four-year research study will determine the clinical usefulness and value of a brain positron emission tomography (PET) scan in diagnosing Alzheimer’s and other dementias. The $100 million Imaging Dementia – Evidence for Amyloid Scanning (IDEAS) Study — jointly conducted by the Alzheimer’s Association and the American College of Radiology (ACR) — will look at the value of PET in certain situations in detecting a core feature of Alzheimer’s disease.
The Alzheimer's Association is disappointed by the Centers for Medicare & Medicaid Services (CMS) decision to allow only Coverage with Evidence Development (CED) for an Alzheimer's imaging test that would improve diagnostic accuracy and certainty in challenging cases. When used in specific populations, as outlined in criteria developed by the Alzheimer's Association and the Society for Nuclear Medicine and Molecular Imaging (SNMMI), this tool has the potential to help identify amyloid in the brain, a hallmark of Alzheimer's disease, and resolve distressing medical uncertainty.
July 28, 2008 – Scientists have captured images of brain lesions similar to those found in Alzheimer’s disease using ...